ReportWire

Tag: Substance Abuse and Mental Health Services Administration

  • Gloria Gaynor And Marijuana

    [ad_1]

    She made a song an anthem – but what about Gloria and cannabis?

    She is timeless disco icon best known for the anthem “I Will Survive,” has openly revealed she needed help in managing the relentless pressure of touring—not as a dependency, but as a tool for stress relief. Gloria Gaynor and marijuana is an example of how the green plant can help those in need. Gaynor described using “marijuana to offset the stress of a hard-hustling touring schedule,” noting it was her go-to choice during moments of overwhelm—“Champagne was my drink. My drug of choice at the time was marijuana”

    RELATED: Guess Who Is A Big Supporter Of Legalizing Marijuana

    Importantly, Gloria insists she never battled a drug addiction. Her usage appears controlled and contextual—something to help her stay grounded amid touring rather than fueling any substance dependency narrative.

    Cannabis is increasingly recognized—especially in journalistic and wellness circles—for its potential to ease anxiety. Many experience benefits such as lowered stress, improved mood, and enhanced relaxation. These anecdotal and studied outcomes align with what Gaynor experienced: a way to soothe nerves and maintain mental equilibrium during grueling work periods.

    He most well know hit “I Will Survive” was released in late 1978, it was quietly placed on the B-side of the single “Substitute.” But the song had a backstory making it anything but ordinary. Gaynor had recently undergone spinal surgery, a moment leaving her uncertain about her career. The lyrics, written by Freddie Perren and Dino Fekaris, resonated deeply with her own journey of recovery and resilience.

    “It spoke to everything I was going through — physically, emotionally, spiritually,” Gaynor recalled. “I knew this song could give people hope.”

    Rather than letting it languish in obscurity, she personally handed the track to DJs at New York’s Studio 54. The club’s pulsating lights and late-night crowd became the launchpad for its success. Within months, the single shot to No. 1 on the Billboard Hot 100, eventually winning the only Grammy ever awarded for Best Disco Recording.

    RELATED: Mixed Messages From The Feds About Cannabis

    With its driving beat and defiant lyrics, “I Will Survive” became more than just a dance floor hit — it was a lifeline for listeners facing breakups, illness, discrimination, or personal loss. Rolling Stone would later rank it among the greatest songs of all time.

    Beyond “I Will Survive,” Gaynor’s catalog includes the exuberant “I Am What I Am” (1983), which found special resonance in the gay community, and disco hits like “How High the Moon” and “Casanova Brown.” Each reflects her unmistakable voice and her ability to connect with listeners through themes of authenticity and self-belief.

    Today, Gaynor’s story is one of longevity, not cringe. She continues to perform, inspire, and advocate for resilience in all forms — whether through music, faith, or a little help from a plant which, for her, was simply another way to survive.

    [ad_2]

    Sarah Johns

    Source link

  • Latest Data Reveals Youth Marijuana Use

    [ad_1]

    The government has released  data on youth cannabis use – and the numbers are not surprising

    One of the concerns over legalizing marijuana is use among the under 21, now the latest data reveals youth marijuana use. Despite expanding access, use among young people is not surging. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), past-year marijuana use among individuals aged 12 to 20 declined to 16.7 percent in 2024, the lowest level seen in four years—even as more states legalize cannabis for adults.

    RELATED: Guess Who Is A Big Supporter Of Legalizing Marijuana

    This finding runs counter to fears legalization would automatically spark a spike in adolescent use. In fact, the report reveals a drop from 17.9 percent in 2021 and 19.2 percent in 2022, signaling a downward trend in youth consumption despite broader adult access.  It has long been a talking point of those opposing legalization it will cause youth use to soar, but the federal government consistentl shows a decline in use.

    Data from the Centers for Disease Control and Prevention (CDC) reinforce this trend. Their Youth Risk Behavior Survey shows past-month marijuana use among high school students fell from 23 percent in 2013 to 17 percent in 2023, as alcohol use also declined. Another CDC report focusing on early legalizing states—Colorado, Oregon, and Washington—found no uptick in adolescent usage following legalization.

    These government sources highlight legalization, when paired with education and regulation, does not necessarily translate to increased youth consumption. For further reference, SAMHSA’s National Survey on Drug Use and Health (NSDUH)—which provided these results—is available at SAMHSA.gov. Additionally, youth data from the CDC’s YRBSS (Youth Risk Behavior Surveillance System) offers more granular insights.

    • Fully legalized (recreational + medical): 24 states and the District of Columbia have legalized both medical and recreational marijuana.

    • Medical-only legalization: 40 states permit medical cannabis use, while medical-only laws remain in effect where recreational laws have not been adopted.

    RELATED: Mixed Messages From The Feds About Cannabis

    At the federal level, marijuana remains a Schedule I drug under the Controlled Substances Act, alongside substances like heroin and LSD. But change may be on the horizon. President Trump has confirmed his administration is “looking at” rescheduling marijuana—from Schedule I to Schedule III—and expects to make a determination in the coming weeks.

    This review follows a prior process initiated belatedly under the Biden administration: in August 2023, the Department of Health and Human Services recommended rescheduling, and the DEA began rulemaking including hearings—though the process is now paused pending appeals.

    A successful reclassification could pave the way for more medical research, easier banking access for cannabis businesses, and tax benefits for the industry—without fully legalizing marijuana at the federal level.

    [ad_2]

    Terry Hacienda

    Source link